Search Results - "De Man, R."

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes by Baven‐Pronk, A. M. C., Coenraad, M. J., van Buuren, H. R., de Man, R. A., van Erpecum, K. J., Lamers, M. M. H., Drenth, J. P. H., van den Berg, A. P., Beuers, U. H., den Ouden, J., Koek, G. H., van Nieuwkerk, C. M. J., Bouma, G., Brouwer, J. T., van Hoek, B.

“…Aliment Pharmacol Ther 2011; 34: 335–343 Summary Background  Treatment failure occurs in 20% of autoimmune hepatitis patients on prednisolone and azathioprine…”
Get full text

SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma by Hernanda, P Y, Chen, K, Das, A M, Sideras, K, Wang, W, Li, J, Cao, W, Bots, S J A, Kodach, L L, de Man, R A, Ijzermans, J N M, Janssen, H L A, Stubbs, A P, Sprengers, D, Bruno, M J, Metselaar, H J, ten Hagen, T L M, Kwekkeboom, J, Peppelenbosch, M P, Pan, Q

“…Further understanding of the molecular biology and pathogenesis of hepatocellular carcinoma (HCC) is crucial for future therapeutic development. SMAD4,…”
Get full text

The long-term outcome of the Kasai operation in patients with biliary atresia: a systematic review by Bijl, E J, Bharwani, K D, Houwen, R H J, de Man, R A

“…Biliary atresia (BA) is a progressive inflammatory destructive process of the bile ducts occurring in about one of every 20,000 live births. If left untreated,…”
Get full text

Systematic review of haemorrhage and rupture of hepatocellular adenomas by van Aalten, S. M., de Man, R. A., IJzermans, J. N. M., Terkivatan, T.

“…Background: Although benign in itself, hepatocellular adenoma (HCA) can be complicated by hormone‐induced growth, and subsequent haemorrhage and rupture. The…”
Get full text

Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection by van Zonneveld, M., van Nunen, A. B., Niesters, H. G. M., de Man, R. A., Schalm, S. W., Janssen, H. L. A.

“…Vertical transmission of hepatitis B virus (HBV) can occur occasionally despite vaccination of the child. This vaccination breakthrough has been associated…”
Get full text

Exacerbation of chronic hepatitis B infection after delivery by Ter Borg, M. J., Leemans, W. F., De Man, R. A., Janssen, H. L. A.

“…During pregnancy several alterations in the immune status allow mothers to tolerate the genetically different foetal tissues. We investigated the evolution of…”
Get full text

Safety and efficacy of transarterial embolization of hepatocellular adenomas by van Rosmalen, B. V., Klompenhouwer, A. J., de Graeff, J. Jaap, Haring, M. P. D., de Meijer, V. E., Rifai, L., Dokmak, S., Rawashdeh, A., Abu Hilal, M., de Jong, M. C., Dejong, C. H. C., Doukas, M., de Man, R. A., IJzermans, J. N. M., van Delden, O. M., Verheij, J., van Gulik, T. M.

“…Background Hepatocellular adenoma (HCA) larger than 5 cm in diameter has an increased risk of haemorrhage and malignant transformation, and is considered an…”
Get full text

Case-orientated approach to the management of hepatocellular adenoma by van der Windt, D. J., Kok, N. F. M., Hussain, S. M., Zondervan, P. E., Alwayn, I. P. J., de Man, R. A., IJzermans, J. N. M.

“…Background: Treatment of suspected hepatocellular adenoma (HA) remains controversial. The aim of this study was to evaluate the management of HA at a time when…”
Get full text

The long-term outcome of patients with polycystic liver disease treated with lanreotide by Chrispijn, M., Nevens, F., Gevers, T. J. G., Vanslembrouck, R., van Oijen, M. G. H., Coudyzer, W., Hoffmann, A. L., Dekker, H. M., de Man, R. A., van Keimpema, L., Drenth, J. P. H.

“…Aliment Pharmacol Ther 2012; 35: 266–274 Summary Background  Polycystic liver disease (PLD) is a phenotypical expression of autosomal dominant polycystic…”
Get full text

Broad-Range PCR in Selected Episodes of Prosthetic Joint Infection by De Man, F. H. R, Graber, P, Lüem, M, Zimmerli, W, Ochsner, P. E, Sendi, P

Get full text

Determinants of quality of life in chronic liver patients by GUTTELING, J. J., DE MAN, R. A., VAN DER PLAS, S. M., SCHALM, S. W., BUSSCHBACH, J. J. V., DARLINGTON, A.‐S. E.

“…Summary Background and aim Health‐related quality of life of patients with chronic liver disease has been shown to be impaired in numerous studies. However,…”
Get full text

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase by van Nunen, A B, Hansen, B E, Suh, D J, Löhr, H F, Chemello, L, Fontaine, H, Heathcote, J, Song, B C, Janssen, H L A, de Man, R A, Schalm, S W

“…Background and aims: Interferon (IFN) induced hepatitis B e antigen (HBeAg) seroconversion is durable in 80–90% of chronic hepatitis B patients. Preliminary…”
Get full text

Gastrointestinal: Rare cause of hematemesis initially presenting as a bleeding gastric Dieulafoy's lesion by de Jonge, Pjf, de Man, R A, van Buuren, H R

Get full text

A prospective study on elective umbilical hernia repair in patients with liver cirrhosis and ascites by Eker, Hasan H., MD, van Ramshorst, G.H., MD, de Goede, B., MSc (Res), Tilanus, H.W., MD, PhD, Metselaar, H.J., MD, PhD, de Man, R.A., MD, PhD, Lange, J.F., MD, PhD, Kazemier, G., MD, PhD

“…Background Patients with both cirrhosis and ascites have a 20% risk of developing umbilical hernia. A retrospective study from our center comparing…”
Get full text

Lamivudine therapy for chronic hepatitis B: A six-month randomized dose- ranging study by Nevens, F, Main, J, Honkoop, P, Tyrrell, DL, Barber, J, Sullivan, MT, Fevery, J, De Man, RA, Thomas, HC

“…BACKGROUND & AIMS: Lamivudine inhibits hepatitis B virus replication. This study investigated 6 months of lamivudine treatment at three doses. METHODS:…”
Get full text

Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonresponders by Schiff, Eugene R, Dienstag, Jules L, Karayalcin, Selim, Grimm, Ian S, Perrillo, Robert P, Husa, Petr, de Man, R.A, Goodman, Zachary, Condreay, Lynn D, Crowther, Lynn M, Woessner, Mary A, McPhillips, Penny J, Brown, Nathaniel A

“…Background/Aims: Lamivudine is effective in treatment-naive patients with chronic hepatitis B, but its role in interferon nonresponders has not been described…”
Get full text

Development of a Quantitative Real-Time Detection Assay for Hepatitis B Virus DNA and Comparison with Two Commercial Assays by PAS, S. D, FRIES, E, DE MAN, R. A, OSTERHAUS, A. D. M. E, NIESTERS, H. G. M

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

A second-generation virtual reality simulator for colonoscopy: validation and initial experience by Koch, A D, Haringsma, J, Schoon, E J, de Man, R A, Kuipers, E J

“…Simulators are increasingly used in skills training for physicians; however data on systematic evaluation of the performance of these simulators are scarce…”
Get more information

The safety of pegylated interferon alpha‐2b in the treatment of chronic hepatitis B: predictive factors for dose reduction and treatment discontinuation by Zonneveld, M., Flink, H. J., Verhey, E., Senturk, H., Zeuzem, S., Akarca, U. S., Cakaloglu, Y., Simon, C., So, T. M. K., Gerken, G., Man, R. A., Hansen, B. E., Schalm, S. W., Janssen, H. L. A.

“…Summary Background : Treatment with interferon‐alpha has been shown to be effective in one‐third of hepatitis B e antigen‐positive chronic hepatitis B…”
Get full text

Entecavir: a potent new antiviral drug for hepatitis B by Honkoop, P, De Man, R A

“…Entecavir, a new deoxyguanine nucleoside analogue, is a selective inhibitor of the replication of the hepatitis B virus. In vitro this compound has proven to…”
Get more information